Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis

ClinicalTrials.gov ID: NCT01532336

Public ClinicalTrials.gov record NCT01532336. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 8:27 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized Study of the Efficacy and Safety of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the clinical and microbiological efficacy and safety of NVC-422 compared to vehicle for adenoviral conjunctivitis. Adults and children one year of age and older with diagnosis of adenoviral conjunctivitis in at least one eye based upon a positive adenovirus test result using the Aden-Detactor Plus kit (Rapid Pathogen Screening, Inc). Subjects will be randomly assigned to receive either NVC-422 or Vehicle.

Study identification

NCT ID
NCT01532336
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NovaBay Pharmaceuticals, Inc.
Industry
Enrollment
500 participants

Conditions and interventions

Eligibility (public fields only)

Age range
1 Year and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2012 (Type not available)
Primary completion
May 2014 (Actual)
Completion
Aug 2014 (Actual)
Last update posted
May 28, 2015

2012 – 2014

United States locations

U.S. sites
24
U.S. states
13
U.S. cities
24
Facility City State ZIP Site status
Not listed Glendale California 91205 —
Not listed Los Angeles California 90048 —
Not listed Petaluma California 94954 —
Not listed San Diego California 92115 —
Not listed Fort Myers Florida 33901 —
Not listed Jacksonville Beach Florida 32250 —
Not listed Tampa Florida 33603 —
Not listed Albany Georgia 31701 —
Not listed Kailua Hawaii 96734 —
Not listed Glenview Illinois 60026 —
Not listed Peoria Illinois 61615 —
Not listed Shawnee Mission Kansas 66204 —
Not listed Hazard Kentucky 41701 —
Not listed Winchester Massachusetts 01890 —
Not listed Kansas City Missouri 64154 —
Not listed St Louis Missouri 63131 —
Not listed Hicksville New York 11801 —
Not listed Rockville Centre New York 11570 —
Not listed Asheville North Carolina 28803 —
Not listed High Point North Carolina 27262 —
Not listed Winston-Salem North Carolina 27101 —
Not listed Pittsburgh Pennsylvania 15206 —
Not listed Charleston South Carolina 29414 —
Not listed Spartanburg South Carolina 29306 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01532336, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2015 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01532336 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →